OUR PRODUCTS

MOBILE APPS

GENERAL INFO

NAMS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

NewAmsterdam Pharma (NAMS) Earnings Date & Reports

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NAMS is expected to report earnings to rise 204.45% to -45 cents per share on November 17

NewAmsterdam Pharma NAMS Stock Earnings Reports

Q3'25

Est.

$-0.45

Q2'25

Beat

by $0.35

Q1'25

Beat

by $0.16

Q4'24

Beat

by $0.03

Q3'24

Beat

by $0.32

The last earnings report on August 06 showed earnings per share of -14 cents, beating the estimate of -49 cents. With 1.88M shares outstanding, the current market capitalization sits at 2.85B.

View a ticker or compare two or three

Compare

NAMS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NAMS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NAMS showed earnings on August 06, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Gooimeer 2-35

Phone

+31 352062971

Employees

Web

https://www.newamsterdampharma.com